President Trump’s April 15 executive order seeks to delay Medicare price negotiations for small molecule drugs, aiming to balance innovation incentives with cost savings for beneficiaries.
Leave a Commentcritical issues and critical thinking
President Trump’s April 15 executive order seeks to delay Medicare price negotiations for small molecule drugs, aiming to balance innovation incentives with cost savings for beneficiaries.
Leave a Comment